Sign In
to Vote &
Create Storyboards.
 
(NIH/National Institute of Allergy and Infectious Diseases) A novel, gene-based investigational vaccine protected mice and monkeys against Zika virus infection after a single dose, according to a study appearing online in the journal Nature on Feb. 2. The candidate vaccine iscalled ZIKV prM-E mRNA-LNP. Scientists at the University of Pennsylvania in Philadelphia and at the company BioNTech in Mainz, Germany, developed the vaccine. The research was conducted by investigators funded by NIAID, NIAI...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard